Academic pharmacist Nataly Martini discusses the medical management of asthma in adults and adolescents, which has evolved to prioritise early anti-inflammatory treatment. She also explains how to improve patient outcomes by proactively identifying poor asthma control and supporting equitable access to education and treatment
Lessening the burden of chronic conditions

After years of talking to patients with long-term conditions about their medications, Christchurch pharmacist Katrina Azer critiques existing services and urges a new approach for the good of patients and health-sector budgets
Kia ora and welcome to Pharmacy Today Kaitiaki Rongoā O Te Wā
Not a subscriber? Unlock this article by subscribing here.
1 - Ministry of Health. 2009. Report on New Zealand Cost-of-Illness Studies on Long-Term Conditions. Wellington: Ministry of Health. https://www.health.govt.nz/system/files/documents/publications/nz-cost-of-illness-jul09.pdf
2 - Deaths caused by diabetes mellitus (all types) in New Zealand - Figure.nz https://figure.nz/chart/jFmzkvRLFLUeU0Zd-ViULDwwJPdYD6lk5
3 - Ministry of Health - Budget 2021: Vote Health https://www.health.govt.nz/about-ministry/what-we-do/budget-2021-vote-health#:~:text=PHARMAC's%20ongoing%20medicines%20budget%20for,now%20a%20record%20%241.085%20billion
4 - Adepoju O.E, Chae M, Liaw W, Angelocci T, Millard P, Matuk-Villazona O. Transition to telemedicine and its impact on missed appointments in community-based clinics. Ann Med. 2022; 54(1): 98–107.
5 - Leporini C, De Sarro G, Russo E. Adherence to therapy and adverse drug reactions: is there a link? Expert Opin Drug Safety.2014 Sep;13 Suppl 1:S41-55.
6 - Foley L, Larkin J, Lombard-Vance R, Murphy A et al. Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis. BMJ Open 2021;11:e044987. doi: 10.1136/bmjopen-2020-044987
7 - Martini N D, Van der Werf B, Bassett-Clarke B. Primary medication non-adherence at Counties Manukau Health Emergency Department (CMH-ED), New Zealand: an observational study BMJ Open 2020;10:e035775. doi: 10.1136/bmjopen-2019-035775
8 - Report: The economic impact of nonadherence: Microsimulation modelling for HIV/AIDS in NZ NZAE Conference paper May 2012 - Chris Schilling, Bill Kaye-Blake, James Allen, and Lulu Zeng
9 - Lynne T - Drug non-adherence "costing NHS £500M+ a year": PharmaTimes https://www.pharmatimes.com/news/drug_non-adherence_costing_nhs_500m_a_year_1004468#:~:text=People%20who%20do%20not%20take,a%20new%20study%20has%20reported